Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 670.5 JPY 0.39% Market Closed
Market Cap: 606.7B JPY
Have any thoughts about
Santen Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Santen Pharmaceutical Co Ltd

Wall Street analysts forecast Santen Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Santen Pharmaceutical Co Ltd is 2 145.06 JPY with a low forecast of 1 717 JPY and a high forecast of 2 730 JPY.

Lowest
Price Target
1 717 JPY
3% Upside
Average
Price Target
2 145.06 JPY
28% Upside
Highest
Price Target
2 730 JPY
63% Upside
Santen Pharmaceutical Co Ltd Competitors:
Price Targets
300723
Yipinhong Pharmaceutical Co Ltd
68% Upside
MMQ
Mind Medicine (MindMed) Inc
236% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
22% Upside
APLLTD
Alembic Pharmaceuticals Ltd
15% Upside
GLS
Glenmark Life Sciences Ltd
5% Upside
NEU
Neuren Pharmaceuticals Ltd
126% Upside
EAPI
Euroapi SAS
3% Downside
CPH
Cipher Pharmaceuticals Inc
24% Upside

Revenue
Forecast

Revenue Estimate
Santen Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Santen Pharmaceutical Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is 1%.

6%
Past Growth
1%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Santen Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Santen Pharmaceutical Co Ltd's operating income is -5%. The projected CAGR for the next 2 years is 0%.

-5%
Past Growth
0%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Net Income
Forecast

Net Income Estimate
Santen Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Santen Pharmaceutical Co Ltd's net income is -8%. The projected CAGR for the next 3 years is 17%.

-8%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Santen Pharmaceutical Co Ltd's stock price target?
Price Target
2 145.06 JPY

According to Wall Street analysts, the average 1-year price target for Santen Pharmaceutical Co Ltd is 2 145.06 JPY with a low forecast of 1 717 JPY and a high forecast of 2 730 JPY.

What is Santen Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
1%

For the last 8 years the compound annual growth rate for Santen Pharmaceutical Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is 1%.

What is Santen Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
0%

For the last 8 years the compound annual growth rate for Santen Pharmaceutical Co Ltd's operating income is -5%. The projected CAGR for the next 2 years is 0%.

What is Santen Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Santen Pharmaceutical Co Ltd's net income is -8%. The projected CAGR for the next 3 years is 17%.

Back to Top